Physician & Healthcare Provider Referral Portal | CĒD Clinic
Physician & Healthcare Provider Referral Portal
A dedicated collaborative care pipeline connecting primary care physicians, oncologists, pediatricians, and specialists with evidence-based cannabinoid medicine consultations.
How We Partner with Your Clinical Practice
CĒD Clinic operates strictly as a specialized consultative resource. We never replace the primary medical team or discontinue established pharmacotherapies without mutual clinician communication.
Direct Provider Referral
Submit your patient’s clinical summary, active medication list, and primary symptom targets via our secure HIPAA portal or clinical fax.
60-Min Clinical Evaluation
Dr. Benjamin Caplan conducts an exhaustive 1-on-1 virtual or in-clinic assessment reviewing symptom history, prior sensitivities, and pharmacology.
Titration & Safety Protocol
A personalized cannabinoid regimen is formulated detailing precise milligram starting windows, terpene profiles, administration routes, and CYP450 drug interaction screening.
Formal Clinical Note to EMR
A comprehensive consultation summary with objective monitoring metrics is securely transmitted directly back to your medical record system for care continuity.
Primary Clinical Referral Indications
Physicians frequently refer patients when standard first-line therapies have yielded suboptimal relief, intolerable side effects, or high dependency risks:
⚡ Intractable Chronic Pain & Opioids
For patients suffering from neuropathic pain, fibromyalgia, or post-surgical pain requiring harm-reduction strategies.
- Objective: Opioid-sparing and reduction of high-dose NSAID gastrointestinal risk
- Focus: Biphasic CB1/CB2 synergy to gate central pain signaling
- View Opioid-Sparing Research Series ↗
🎗️ Oncology & Chemotherapy Support
Collaborating alongside oncology teams to manage treatment-related toxicity and improve nutritional resilience.
- Objective: Chemotherapy-induced peripheral neuropathy (CIPN), anticipatory nausea, cachexia
- Focus: Whole-plant formulation with calibrated anti-emetic profiles
- View Ethan Zohn Oncology Series ↗
🧩 Pediatric Neurodevelopment & Severe Autism
Specialized clinical evaluations for complex pediatric patients exhibiting profound sensory dysregulation.
- Objective: Reducing severe self-injurious behaviors, aggressive escalation, and sleep disruption
- Focus: Non-intoxicating CBDA, CBD, and minor cannabinoid titration under two-physician oversight
- View Pediatric Autism Clinical Feature ↗
👵 Geriatric Medicine & Polypharmacy
Carefully titrating cannabinoids for older adults to de-prescribe sedatives and reduce nighttime confusion.
- Objective: Improving sleep onset, easing osteoarthritic joint pain, mitigating fall hazards
- Focus: Ultra-low threshold titration (0.5–1 mg THC + CBG) taking hepatic clearance into account
- View Seniors Wellness Series ↗
🧠 Neurodegenerative Conditions (MS & Parkinson’s)
Addressing nocturnal spasticity, rigidity, tremor, and neurogenic bladder dysfunction.
- Objective: Relieving painful motor spasms and improving sleep continuity
- Focus: Balanced THC:CBD ratios and anti-spasmodic terpene selection (Myrcene, Caryophyllene)
- View Montel Williams MS Masterclass ↗
🧬 Gastrointestinal & Endocannabinoidome
Targeting visceral hypersensitivity, Crohn’s, ulcerative colitis, and metabolic syndrome.
- Objective: Calming enteric nerve inflammation and restoring gut barrier integrity
- Focus: High-CBG and THCV formulations supporting the microbiome
- View THCV & Gut Science ↗
Secure Provider Referral Channels
Our clinical intake coordinators ensure rapid scheduling for your patients. Most consultations can be conducted via telehealth within 3 to 5 business days, with urgent oncology and pediatric priority slots available:
